Resona Asset Management Co.,Ltd.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1944142
KOTO-KU,TOKYO, M0
Position in SUPN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$420,217
-$83,398 QoQ
Shares Held
9,035
-7.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 331 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Resona Asset Management Co.,Ltd. holds $35,396,772 across 7 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
316,361 | $10,718,310 | |
| 2 | ZTS |
Zoetis Inc.
|
124,635 | $8,956,271 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
15,391 | $8,339,305 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
38,974 | $6,568,677 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
9,035 | $420,217 | |
| 6 | VTRS |
Viatris Inc
|
17,063 | $270,960 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,109 | $123,032 |
All Filings in SUPN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420,217 | 9,035 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $503,615 | 9,743 | Shares | Other | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||